News and Press Releases

Press releases

February 1, 2021

Theralase Releases Quarterly Newsletter

Press Release

Toronto, Ontario – February 01, 2021, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated...

Comments0
January 8, 2021

Theralase Announces Warrant Extension

Press Release

Toronto, Ontario – January 8, 2021, Theralase® Technologies Inc. (“Theralase” or “Company“) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Co...

Comments0

in the news

July 6, 2023

Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer

Watch the video

may 18, 2023

Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni

Watch the video
B-TV Theralase® an innovative medical technology for bladder cancer treatment
August 16, 2018

BTv – Theralase® an innovative medical technology for bladder cancer treatment – 2018

Watch the video
October 10, 2017
Invest in Ontario – Toronto-based Firm Advances Light-activated Cancer Treatment Through SOSCIP Collaboration Program
Watch the video
December 20, 2016
Stock News Now – Update with Theralase Technologies (TSX-V: TLT) (OTC PINK: TLTFF) December 2016
Watch the video
BTv – Theralase Technologies is Destroying Cancer Cells
November 12, 2016

BTv – Theralase Technologies is Destroying Cancer Cells – 2016

Watch the video
BTv – Using Lasers to Heal Pain and Treat Cancer
February 12, 2016

BTv – Using Lasers to Heal Pain and Treat Cancer – 2016

Watch the video
August 31, 2015
The View From The C-Suite – Roger Dumoulin-White, P. Eng, President & CEO, Theralase Technologies Inc.
Watch the video
Theralase® newsletter

Let's Stay in Touch

Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.